Latest filing published 09 Oct 2026 for Pacira BioSciences, Inc., €173k. Read the official filing
All filings by Lauren Riker on record concern Pacira BioSciences, Inc., in the capacity of senior executive. In total, 11 filings cover trades dated from 2 January 2024 to 8 October 2026.
Every open-market trade on record is a sale: 1 sale worth €194k. Besides market trades, the filings include 9 share grants and 1 option exercise. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 9 October 2026, reports an option exercise of €173k in Pacira BioSciences, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations